Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2009; 15(22): 2768-2777
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2768
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2768
Variables | Derivation set n = 172 | Validation set n = 85 |
Follow-up period | 56 (4-104) | 58 (8-104) |
Age (yr) | 56 (20-79) | 59 (23-78) |
Sex, n (%) | ||
Male | 106 (62) | 58 (68) |
Female | 66 (38) | 27 (32) |
Cause of cirrhosis, n (%) | ||
Alcohol | 30 (17) | 16 (19) |
Alcohol plus viral infection | 15 (9) | 4 (5) |
HBV | 20 (12) | 12 (14) |
HCV | 92 (53) | 50 (59) |
Viral co-infection (HBV/HCV) | 1 (1) | 1 (1) |
Unknown | 13 (7) | 1 (1) |
NAFL | 1 (1) | 1 (1) |
Complications on admission, n (%) | ||
Ascites | ||
Absent or controlled | 147 (85) | 72 (85) |
Uncontrolled | 25 (15) | 13 (15) |
BEV | ||
Absent or present without relapses | 167 (97) | 79 (94) |
Present with relapses | 5 (3) | 5 (6) |
Encephalopathy | ||
Absent or controlled | 160 (93) | 79 (93) |
Uncontrolled | 12 (7) | 6 (7) |
SBP | ||
Absent or present without relapses | 168 (98) | 82 (96) |
Present with relapses | 4 (2) | 3 (4) |
Hepatorenal syndrome, n (%) | 3 (2) | 1 (1) |
Prothrombin time (s) | 19 (13-55) | 17 (13-53) |
Partial thromboplastin time (s) | 38 (26-165) | 39 (26-167) |
INR for prothrombin time | 1.7 (1-7.5) | 1.5 (1-6.9) |
Albumin (g/L) | 37 (20-48) | 36 (21-47) |
Creatinine (mmol/L)1 | 100 (42-516) | 98 (39-489) |
Bilirubin (mmol/L)2 | 20 (8-130) | 23 (12-137) |
Cholesterol (mmol/L) | 3.8 (1.9-10.2) | 3.9 (2-9.6) |
Child-Pugh score3 | 7 (5-14) | 7 (5-14) |
Child-Pugh A, n (%) | 67 (39) | 30 (35) |
Child-Pugh B, n (%) | 75 (44) | 34 (40) |
Child-Pugh C, n (%) | 30 (17) | 21 (25) |
MELD score | 17 (9-42) | 18 (10-43) |
BioCliM score | 7.7 (6.1-13.6) | 7.9 (6-13.8) |
Variables | P | Hazard ratio | 95% CI for Hazard ratio |
Age (yr) | 0.68 | 0.56 | 0.36-1.06 |
Sex (male) | 0.54 | 0.44 | 0.89-1.26 |
Etiology (viral) | 0.66 | 0.58 | 0.40-1.11 |
ALT (IU/L) (logn value) | 0.85 | 0.84 | 0.34-1.12 |
AST (IU/L) (logn value) | 0.43 | 0.90 | 0.56-1.34 |
ALT/AST ratio | 0.64 | 0.87 | 0.50-1.21 |
Platelet count (× 109/L) (logn value) | 0.54 | 0.89 | 0.52-1.30 |
Prothrombin time (s)1 (logn value) | 0.01 | 2.23 | 1.24-4.89 |
INR for prothrombin time (logn value) | 0.03 | 1.99 | 1.13-3.96 |
Partial thromboplastin time (s)2 (logn value) | 0.04 | 1.78 | 1.10-3.23 |
Albumin (mg/dL) (logn value) | 0.001 | 3.12 | 1.89-5.23 |
Bilirubin (mmol/L) (logn value) | < 0.001 | 3.89 | 2.12-6.14 |
Creatinine (mmol/L) (logn value) | < 0.001 | 3.95 | 2.18-6.56 |
Cholesterol (mmol/L) (loge value) | 0.03 | 1.83 | 1.34-3,42 |
Ascites | < 0.001 | 4.05 | 2.27-6.33 |
Spontaneous bacterial peritonitis | 0.001 | 3.05 | 2.10-5.07 |
Encephalopathy | < 0.001 | 4.50 | 2.90-6.50 |
Bleeding esophageal varices | < 0.001 | 4.78 | 3.11-7.11 |
Variable | Variable χ2 | Regression coefficient | Hazard ratio | 95% CI for Hazard ratio | P value | c-statistic | BIC | |
Ascites | 53.90 | 2.310 | 10.2 | 3.78 | 28.1 | < 0.0001 | 0.76 | 2014.15 |
+ Ln (creatinine) | 63.43 | 1.370 | 3.99 | 1.57 | 10.9 | 0.006 | 0.83 | 1988.15 |
+ BEV | 65.71 | 1.195 | 3.25 | 1.01 | 9.77 | 0.048 | 0.85 | 1970.65 |
+ HE | 68.91 | 0.909 | 2.50 | 0.915 | 6.88 | 0.070 | 0.89 | 1961.89 |
+ Ln (bilirubin)2 | 70.11 | 0.349 | 1.46 | 0.66 | 3.33 | 0.427 | 0.90 | 1951.77 |
- Citation: Gomez EV, Bertot LC, Oramas BG, Soler EA, Navarro RL, Elias JD, Jiménez OV, Vazquez MDRA. Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease. World J Gastroenterol 2009; 15(22): 2768-2777
- URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2768.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2768